Skip to content
Thursday, February 9, 2023
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending

Featured

BIOTCHNO Featured 

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

April 1, 2021August 4, 2021 RJ

Canada NewsWire Test Designed to Assist in Identifying Severe Inflammatory Response in Patients with Confirmed COVID-19 Illness TORONTO , April

Read more
BIOTCHNO Featured 

LaunchLife International Announces the Relaunch of Student Tutoring APP tutit

February 11, 2021April 8, 2021 Bachittar

LaunchLife International Announces the Relaunch of Student Tutoring APP tutit The Newly Redesigned Tutit App and Website Allow Better Student

Read more

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057